default author photo

Carina A. Rodriguez

University of South Florida - Morsani College of Medicine

SCHOLARLY PAPERS

2

DOWNLOADS

313

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Risk of COVID-19 after Natural Infection or Vaccination

Number of pages: 24 Posted: 01 May 2023
University of Pittsburgh - Department of Pediatrics, University of Maryland, Baltimore (UMB) - School of Medicine, Fred Hutchinson Cancer Research Center, affiliation not provided to SSRN, Fred Hutchinson Cancer Research Center, University of California, San Diego (UCSD) - Division of Infectious Diseases and Global Public Health, University of South Florida - Morsani College of Medicine, Emory University School of Medicine and Children’s Healthcare of Atlanta - Department of Pediatrics, Ndlovu Research Centre, Harvard University - Brigham and Women’s Hospital, Baylor College of Medicine, Instituto Nacional de Infectologia Evandro Chagas, Fiocruz - Lab. De Pesquisa Clinica DST/AIDS, South African Medical Research Council, University of North Carolina (UNC) at Chapel Hill - School of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Moderna, Inc., AstraZeneca Pharmaceuticals, Janssen Research & Development, LLC, Novavax, Inc., - Center for Vaccine Development and Global Health, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Alabama at Birmingham - Heersink School of Medicine, Harvard University - Brigham and Women’s Hospital, Government of the United States of America - Biostatistics Research Branch and - Department of Pediatrics
Downloads 228 (334,744)

Abstract:

Loading...

COVID-19, natural infection, hybrid immunity, vaccination

2.

Bictegravir, Emtricitabine, and Tenofovir Alafenamide Fixed-Dose Combination for Treatment of HIV in Adolescents and Children: Week 48 Results from an Open-Label, Multicentre, Phase 2/3 Paediatric Trial

Number of pages: 35 Posted: 01 Sep 2020
Department of Infectious Diseases, St. Jude Children’s Research Hospital, Stellenbosch University, University of South Florida - Morsani College of Medicine, Department of Pediatrics at the Wayne State University School of Medicine, Be Part Yoluntu Centre, Chris Hani Baragwanath Academic Hospital, Joint Clinical Research Centre, Faculty of Medicine, Khon Kaen University, Mahidol University - Siriraj Institute of Clinical Research (SICRES), Department of Portfolio Project Management, Gilead Sciences, Gilead Sciences, Inc., Gilead Sciences, Inc., Department of Clinical Pharmacology, Gilead Sciences, Department of Virology Clinical Research, Gilead Sciences, Federal Reserve Bank of Cleveland, Gilead Sciences, Inc. and Department of Virology Clinical Research, Gilead Science
Downloads 85 (771,553)

Abstract:

Loading...

paediatric, HIV, INSTI, bictegravir, tenofovir alafenamide